Sotoodeh Abhary
Overview
Explore the profile of Sotoodeh Abhary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu E, Kaidonis G, McComish B, Gillies M, Abhary S, Essex R, et al.
Invest Ophthalmol Vis Sci
. 2019 Sep;
60(12):3937-3942.
PMID: 31546259
Purpose: Few studies have explored the association of genetic variants in microRNA genes and binding sites with diabetic retinopathy (DR) in type 1 diabetes. We conducted a genome-wide scan for...
2.
Liu E, Kaidonis G, Gillies M, Abhary S, Essex R, Chang J, et al.
Sci Rep
. 2019 Jan;
9(1):612.
PMID: 30679766
Mitochondrial haplogroups H1, H2 and UK have previously been reported to be associated with proliferative diabetic retinopathy (PDR) in Caucasian patients with diabetes. We aimed to replicate this finding with...
3.
Graham P, Kaidonis G, Abhary S, Gillies M, Daniell M, Essex R, et al.
BMC Med Genet
. 2018 May;
19(1):71.
PMID: 29739359
Background: Diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) are sight-threatening complications of diabetes mellitus and leading causes of adult-onset blindness worldwide. Genetic risk factors for diabetic retinopathy (DR)...
4.
Kaidonis G, Gillies M, Abhary S, Liu E, Essex R, Chang J, et al.
Acta Diabetol
. 2016 Mar;
53(4):643-50.
PMID: 26997512
Aims: This study aimed to investigate whether the single-nucleotide polymorphism (SNP) rs2910164 residing within microRNA-146a (miR-146a) is associated with diabetic microvascular complications diabetic nephropathy (DN), proliferative diabetic retinopathy (PDR) or...
5.
Kaidonis G, Craig J, Gillies M, Abhary S, Essex R, Chang J, et al.
Diab Vasc Dis Res
. 2016 Jan;
13(2):164-7.
PMID: 26821796
Aim: To investigate, in a large cohort of 2494 individuals with diabetes mellitus, whether functional single nucleotide polymorphisms in the promoter region of tumour necrosis factor (TNF) and lymphotoxin-alpha (LTA)...
6.
Burdon K, Fogarty R, Shen W, Abhary S, Kaidonis G, Appukuttan B, et al.
Diabetologia
. 2015 Jul;
58(10):2288-97.
PMID: 26188370
Aims/hypothesis: Diabetic retinopathy is a serious complication of diabetes mellitus and can lead to blindness. A genetic component, in addition to traditional risk factors, has been well described although strong...
7.
Kaidonis G, Burdon K, Gillies M, Abhary S, Essex R, Chang J, et al.
Ophthalmology
. 2015 Jun;
122(9):1828-36.
PMID: 26072347
Purpose: To investigate associations between single nucleotide polymorphisms (SNPs) in the VEGFC gene and the development of diabetic retinopathy (DR) in white patients with type 1 diabetes mellitus (T1DM) or...
8.
Kaidonis G, Abhary S, Daniell M, Gillies M, Fogarty R, Petrovsky N, et al.
Clin Exp Ophthalmol
. 2013 Oct;
42(5):486-93.
PMID: 24112246
Background: Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology,...
9.
Fogarty R, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting M, et al.
J Diabetes Complications
. 2012 Apr;
26(3):195-8.
PMID: 22521321
Asymmetric dimethylarginine (ADMA) levels are elevated in diabetes and likely contribute to diabetic complications such as retinopathy and nephropathy. The DDAH enzymes are primarily responsible for ADMA metabolism. Polymorphisms in...
10.
Javadiyan S, Burdon K, Whiting M, Abhary S, Straga T, Hewitt A, et al.
Invest Ophthalmol Vis Sci
. 2012 Mar;
53(4):1923-7.
PMID: 22395885
Purpose: Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are the dimethylated isomeric derivatives of the amino acid L-arginine. ADMA is an endogenous inhibitor of nitric oxide synthase (NOS), while SDMA...